Synonyms(4): ABOB | SKF 8898-A | SKF-8898-A | SKF-8898A Synonyms from Alternative Forms(4):
Canonical SMILES: N=C(N)NC(=N)N1CCOCC1
Standard InChI: InChI=1S/C6H13N5O/c7-5(8)10-6(9)11-1-3-12-4-2-11/h1-4H2,(H5,7,8,9,10)
Standard InChI Key: KJHOZAZQWVKILO-UHFFFAOYSA-N
Associated Targets(Human)
Prelamin-A/C 36751 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Cytochrome P450 2C9 32119 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Cytochrome P450 3A4 53859 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Cytochrome P450 2C19 29246 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Cytochrome P450 1A2 26471 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Cytochrome P450 2D6 33882 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Trace amine-associated receptor 1 1397 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Histone deacetylase 6 20808 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Associated Targets(non-human)
Anthrax lethal factor 7585 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Hepatitis C virus 23859 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Trace amine-associated receptor 1 1619 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Trace amine-associated receptor 5 41 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
SARS-CoV-2 38078 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Molecule Features
Natural Product: Yes
Oral: No
Chemical Probe: No
Parenteral: No
Molecule Type: Small molecule
Topical: No
First In Class: No
Black Box: No
Chirality: Yes
Availability: No
Prodrug: No
Drug Indications
MESH ID
MESH Heading
EFO IDs
EFO Terms
Max Phase for Indication
References
Mechanisms of Action
Mechanism of Action
Action Type
target ID
Target Name
Target Type
Target Organism
Binding Site Name
References
Properties
Molecular Weight: 171.20
Molecular Weight (Monoisotopic): 171.1120
AlogP: -1.26
#Rotatable Bonds: 0
Polar Surface Area: 98.22
Molecular Species: BASE
HBA: 3
HBD: 4
#RO5 Violations: 0
HBA (Lipinski): 6
HBD (Lipinski): 5
#RO5 Violations (Lipinski): 0
CX Acidic pKa:
CX Basic pKa: 11.85
CX LogP: -1.14
CX LogD: -5.70
Aromatic Rings: 0
Heavy Atoms: 12
QED Weighted: 0.27
Np Likeness Score: -1.02
References
1.PubChem BioAssay data set,
2.PubChem BioAssay data set,
3.USP Dictionary of USAN and International Names (2010 edition) and USAN registrations 2007-date,
4.PubChem BioAssay data set,
5.Magri A, Reilly R, Scalacci N, Radi M, Hunter M, Ripoll M, Patel AH, Castagnolo D.. (2015) Rethinking the old antiviral drug moroxydine: Discovery of novel analogues as anti-hepatitis C virus (HCV) agents., 25 (22):[PMID:26428870][10.1016/j.bmcl.2015.09.029]
6.WHO Anatomical Therapeutic Chemical Classification,
7.Tonelli M, Espinoza S, Gainetdinov RR, Cichero E.. (2017) Novel biguanide-based derivatives scouted as TAAR1 agonists: Synthesis, biological evaluation, ADME prediction and molecular docking studies., 127 [PMID:27823885][10.1016/j.ejmech.2016.10.058]
8.Ellen Van Damme. (2021) Screening of ~5500 FDA-approved drugs and clinical candidates for anti-SARS-CoV-2 activity, [10.6019/CHEMBL4651402]
9.Bernhard Ellinger, Justus Dick, Vanessa Lage-Rupprecht, Bruce Schultz, Andrea Zaliani, Marcin Namysl, Stephan Gebel, Ole Pless, Jeanette Reinshagen, Christian Ebeling, Alexander Esser, Marc Jacobs, Carsten Claussen, and Martin Hofmann-Apitius. (2021) HDAC6 screening dataset using tau-based substrate in an enzymatic assay yields selective inhibitors and activators, [10.6019/CHEMBL4808148]
10.Grytsai O, Myrgorodska I, Rocchi S, Ronco C, Benhida R.. (2021) Biguanides drugs: Past success stories and promising future for drug discovery., 224 [PMID:34364161][10.1016/j.ejmech.2021.113726]